(Q82265845)
Statements
Dianicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial (English)
Serena Tonstad
Ingar Holme
scientific article published on 01 November 2010
No description defined